Selection and fine-tuning of the autoimmune T-cell repertoire

Nature Reviews Immunology

Volumn 2, Issue 7, 2002, Pages 487-498

  Anderton, Stephen M ^a   Wraith, David C ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD5 ANTIGEN; HLA DM ANTIGEN; T LYMPHOCYTE RECEPTOR; EPITOPE;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNITY; CELL SELECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS; ANIMAL; AUTOIMMUNE DISEASE; HUMAN; IMMUNOLOGY;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; EPITOPES, T-LYMPHOCYTE; HUMANS; T-LYMPHOCYTES;

EID: 0036631471     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri842     Document Type: Review

References (117)

1. Walker, L. S. K. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11-19 (2002).
2. Maloy, K. J. & Powne, F. Regulatory T cells in the control of immune pathology. Nature Immunol. 2, 816-822 (2001).
3. Margulies, D. H. TCR avidity: it's not how strong you make it, it's how you make it strong. Nature Immunol. 2, 669-670 (2001).
4. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. & McDevitt, H. O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59, 247-255 (1989).
5. Anderton, S. M. Radu, C. G., Lowrey, P. A., Ward, E. S. & Wraith, D. C. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193, 1-11 (2001). Clear evidence for the deletion of self-reactive T cells that express high-affinity TCRs during an in vivo immune response.
6. + T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J. Immunol. 164, 191-200 (2000).
7. Yee, C., Savage, P. A., Lee, P. P., Davis, M. M. & Greenberg, P. D. Isolation of high-avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol. 162, 2227-2234 (1999).
8. Zuniga-Pflucker, J. C. et al. Role of CD4 in thymocyte selection and maturation. J. Exp. Med. 169, 2085-2096 (1989).
9. Chidgey, A. & Boyd, R. Agonist peptide modulates T-cell selection thresholds through qualitative and quantitative shifts in CD8 co-receptor expression. Int. Immunol. 9, 1527-1536 (1997).
10. fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70, 741-750 (1992).
11. Azzam, H. S. et al. Fine tuning of TCR signaling by CD5. J. Immunol. 166, 5464-5472 (2001).
12. Plas, D. R. et al. Direct regulation of ZAP-70 by SHP-1 in T-cell antigen receptor signaling. Science 272, 1173-1176 (1996).
13. Kim, E. Y. & Teh, H. S. TNF type 2 receptor (p75) lowers the threshold of T-cell activation. J. Immunol. 167, 6812-6820 (2001).
14. al-Ramadi, B. K., Jelonek, M. T., Boyd, L. F., Margulies, D. H. & Bothwell, A. L. Lack of strict correlation of functional sensitization with the apparent affinity of MHC-peptide complexes for the TCR. J. Immunol. 155, 662-673 (1995).
15. Kersh, G. J. & Allen, P. M., Structural basis for T-cell recognition of altered peptide ligands: a single T-cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184, 1259-1268 (1996).
16. Wraith, D. C., Bruun, B. & Fairchild, P. J. Cross-reactive antigen recognition by an encephalitogenic T-cell receptor. Implications for T-cell biology and autoimmunity. J. Immunol. 149, 3765-3770 (1992).
17. Anderson, A. C. et al. Autoantigen-responsive T-cell clones demonstrate unfocused TCR Cross-reactivity toward multiple related ligands: implications for autoimmunity. Cell. Immunol. 202, 88-96 (2000).
18. Mason, D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19, 395-404 (1998).
19. Borghans, J. A., Noest, A. J. & De Bcer, R. J. How specific should immunological memory be? J. Immunol. 163, 569-575 (1999).
20. Ashtonnckardt, P. G. et al. Evidence for a differential avidity model of T-cell selection in the thymus. Cell 76, 651-663 (1994).
21. Sebzda, E. et al. Selection of the T-cell repertoire. Annu. Rev. Immunol. 17, 829-874 (1999).
22. Savage, P. A. & Davis, M. M. A kinetic window constricts the T-cell receptor repertoire in the thymus. Immunity 14, 243-252 (2001).
23. Zamvil, S. S. et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324, 258-260 (1986).
24. Harrington, C. J. et al. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein Immunity 8, 571-580 (1998).
25. Targoni, O. S. & Lehmann, P. V. Endogenous myelin basic protein inactivates the high avidity T-cell repertoire. J. Exp. Med. 187, 2055-2063 (1998). References 24 and 25 show that high-avidity MBP-reactive T cells are present in MBP-deficient mice.
26. Tuohy, V. K., Lu, Z., Sobel, R. A., Laursen. R. A. & Lees, M. B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142, 1523-1527 (1989).
27. Anderson, A. C. et al. High frequeney of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191, 761-770 (2000). Lack of autoantigen in the thymus allows a high frequency of PLP-reactive T cells to reach the periphery.
28. Nave, K. A., Lai, C., Bloom, F. E. & Milner, R. J. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl Acad. Sci. USA 84, 5665-5669 (1987).
29. Liu, H., MacKenzie-Graham, A. J., Kim, S. & Voskuhl, R. R. Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP-specific T-cell tolerance. J. Neuroimmunol. 115, 118-126 (2001).
30. Lee, D. S., Ahn, C., Ernst, B., Sprent, J. & Surh, C. D. Thymic selection by a single MHC-peptide ligand: autoreactive T cells are low-affinity cells. Immunity 10, 83-92 (1999).
31. Liu, G. Y. et al. Low-avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407-415 (1995). The administration of superagonist, but not wild-type, MBP peptide deletes TCR-transgenic thymocytes. Therefore, weak peptide-MHC interactions fail to induce central tolerance.
32. Lee, C. et al. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft. J. Exp. Med. 187, 1505-1516 (1998).
33. Fritz, R. B. & Zhao, M. L. Thymic expression of myelin basic protein (MBP). Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP. J. Immunol. 157, 5249-5253 (1996).
34. Carrasco-Mann, E. Shimizu, J., Kanagawa, O. & Unanue, E. R. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156, 450-458 (1996).
35. Ridgway, W. M., Fasso, M. & Fathman, C. G. A new look at MHC and autoimmune disease. Science 284, 749-751 (1999).
36. Offner, H. et al. T-cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats. J. Exp. Med. 170, 355-367 (1989).
37. Kono, D. H. et al. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168, 213-227 (1988).
38. Ota, K. et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346, 163-187 (1990).
39. Anderton, S. M., Viner, N. J., Matharu, P., Lowrey, P. A. & Wraith, D. C. Influence of a dominant cryptic epitope on autoimmune T-cell tolerance. Nature Immunol. 3, 175-181 (2002).
40. Manoury, B. et al. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation, Nature 396, 695-699 (1998).
41. Antoniou, A. N., Blackwood, S. L., Mazzeo, D. & Watts, C. Control of antigen presentation by a single protease cleavage site. Immunity 12, 391-398 (2000).
42. Manoury, B. et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T-cell epitope in MBR Nature Immunol. 3, 169-174 (2002). Antigen processing might infuence thymic deletion by preventing efficient generation of self-peptide-MHC complexes.
43. Grossman, Z. & Paul, W. E. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl Acad. Sci. USA 89, 10365-10369 (1992).
44. Grossman, Z. & Paul, W. E. Autoreactivity, dynamic tuning and selectivity. Curr. Opin. Immunol. 13, 687-698 (2001).
45. Davey, G. M. et al. Preselection thymocytes are more sensitive to T-cell receptor stimulation than mature T cells. J. Exp. Med. 188, 1867-1874 (1998).
46. Sebzda, E. et al. Mature T-cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 183, 1093-1104 (1996).
47. Hogquist, K. A., Jameson, S. C., Carbone, F. R. & Bevan, M. J. TCR antagonists induce positive selection. Cell 76, 17-27 (1994).
48. Lucas, B., Stefanova, I., Yasutomo, K., Dautigny, N. & Germain, R. N. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T-cell repertoire. Immunity 10, 367-376 (1999). References 46-48 provide strong evidence for the tuning of T-cell avidity during thymic maturation.
49. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B. & Allen, P. M. Partial T-cell signaling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T-cell anergy. Cell 79, 913-922 (1994).
50. +-T-cell tolerance by cross-presentation of self-antigens. Immunol. Rev. 165, 267-277 (1998).
51. Goldrath, A. W. & Bevan, M. J. Selecting and maintaining a diverse T-cell repertoire. Nature 402, 255-262 (1999).
52. + T cells. Nature Immunol. 1, 107-111 (2000).
53. Ernst, B., Lee, D. S., Chang, J. M., Sprent, J. & Surh, C. D. The peptide ligands mediating positive selection in the thymus control T-cell survival and homeostatic proliferation in the periphery. Immunity 11, 173-181 (1999).
54. Brocker, T. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 166, 1223-1232 (1997).
55. + T cells in lymphopenic hosts. Immunity 11, 183-190 (1999).
56. Kirberg, J., Berns, A. & von Boehmer H. Peripheral T-cell survival requires continual ligation of the T-cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186, 1269-1275 (1997).
57. Alfonso, C. & Kadsson, L. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18, 113-142 (2000).
58. Viret, C., Wong, F. S. & Janeway, C. A. Jr. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide-self-MHC complex recognition. Immunity 10, 559-568 (1999).
59. Fung-Leung, W.-P. et al. Antigen presentation and T-cell development in H2-M-deficient mice. Science 271, 1278-1281 (1996).
60. + T cells in vivo: multiple thresholds in response to a constant level of antigen presentation J. Immunol. 167, 2030-2039 (2001). This study shows that encounter with self-antigen tunes T-cell-activation thresholds in the periphery.
61. Germain, R. N. & Stefanova, I. The dynamics of T-cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu. Rev. Immunol. 17, 467-522 (1999).
62. Daniels, M. A. et al. CD8 binding to MHC class I molecules is influenced by maturation and T-cell glycosoation. Immunity 15, 1051-1061 (2001).
63. Moody, A. M. et al. Developmentally regulated glycosylation of the CD8 αβ coreceptor stalk modulates ligand binding. Cell 107, 501-512 (2001).
64. Perez-Villar, J. J. et al. CD5 negatively regulates the T-cell antigen receptor signal-transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 19, 2903-2912 (1999).
65. Pena-Rossi, C. et al. Negative regulation of CD4 lineage development and responses by CD5. J. Immunol. 163, 6494-6501 (1999).
66. Smith, K. et al. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194, 1253-1261 (2001).
67. Sen, G., Bikah, G., Venkataraman, C. & Bondada, S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 29, 3319-3328 (1999).
68. Wong, P., Barton, G. M., Forbush, K. A. & Rudensky, A. Y. Dynamic tuning of T-cell reactivity by self-peptide-major histocompatibility complex ligands. J. Exp. Med. 193, 1179-1187 (2001).
69. Nicholson, L. B., Anderson, A. C. & Kuchroo, V. K. Tuning T-cell activation threshold and effector function with cross-reactive peptide ligands. Int. Immunol. 12, 205-213 (2000).
70. Fahmy, T. M., Bieler, J. G., Edidin, M. & Schneck, J. P. Increased TCR avidity after T-cell activation: a mechanism for sensing low-density antigen. Immunity 14, 135-143 (2001).
71. + T cells without selection of higher affinity TCR. Nature Immunol. 2, 711-717 (2001).
72. Smilek, D. E. et al. A single amino-acid change in a myelin basic protein peptide confers the capacity to prevent, rather than induce, experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 88, 9633-9637 (1991).
73. Kim, D. T., Rothbard, J. B., Bloom, D. D. & Fathman, C. G. Quantitative analysis of T-cell activation: role of TCR-ligand density and TCR affinity. J. Immunol. 156, 2737-2742 (1996).
74. Davis, M. M. et al. Ugand recognition by αβ T-cell receptors. Annu. Rev. Immunol. 16, 523-544 (1998).
75. Nicholson, L. B. et al. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl Acad. Sci. USA 95, 264-269 (1998).
76. Savage, P. A., Boniface, J. J. & Davis, M. M. A kinetic basis for T-cell-receptor repertoire selection during an immune response. Immunity 10, 485-492 (1999).
77. Busch, D. H. & Pamer, E. G. T-cell affinity maturation by selective expansion during infection. J. Exp. Med. 189, 701-710 (1999).
78. + T-cell response in vivo. J. Exp. Med. 192, 1719-1730 (2000). This paper describes the selection of moderate-affinity TCRs during an immune response.
79. + T-cell responses in vivo and in vitro. Proc. Natl Acad. Sci. USA 96, 9781-9786 (1999). The loss of high-affinity TCRs can be caused by high antigen doses in vivo and in vitro.
80. Zugel, U. et al Termination of peripheral tolerance to a T-cell epitope by heteroclitic antigen analogues. J. Immunol. 161, 1705-1709 (1998).
81. Wang, R., Wang-Zhu, Y., Gabaglia, C. R., Kimachi, K. & Grey, H. M. The stimulation of low-affinity, non-tolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T-cell epitope. J. Exp. Med. 190, 983-994 (1999).
82. Falk, K., Rotzschke, O. & Strominger, J. L. Antigen-specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306-318. Eur. J. Immunol. 30, 3012-3020 (2000).
83. Mitchison, N. A The dosage requirements for immunological paralysis by soluble proteins. Immunology 15, 509-530 (1968).
84. Liblau, R. S. et al. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc. Natl Acad. Sci. USA 93, 3031-3036 (1996).
85. Critchfield, J. M. et al. T-cell deletion in high-antigen-dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143 (1994).
86. Gaur, A. et al. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J. Neuroimmunol. 74, 149-158 (1997).
87. Lenardo, M. et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).
88. Pearson, C. I., van Ewijk, W. & McDevitt, H. O. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T-cell-receptor-transgenic mice. J. Exp. Med. 185, 583-599 (1997).
89. Fujinami, R. S. & Oldstone, M. B. Amino-acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043-1045 (1985).
90. Sandberg, J. K. et al. T-cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J. Immunol. 165, 25-33 (2000).
91. Bouneaud, C., Kourilsky, P. & Bousso, P. Impact of negative selection on the T-cell repertoire reactive to a self-peptide: a large fraction of T-cell clones escapes clonal deletion. Immunity 13, 829-840 (2000). References 90 and 91 show that a proportion of self-reactive TCR-transgenic T cells avoid deletion, but that they are of low avidity.
92. Harding, C. V. & Unanue, E. R. Quantitation of antigen-presenting cell MHC class-II-peptide complexes necessary for T-cell stimulation. Nature 346, 574-576 (1990).
93. Kimachi, K., Croft, M. & Grey, H. M. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells. Eur. J. Immunol. 27, 3310-3317 (1997).
94. Valitutti, S., Muller, S, Cella, M., Padovan, E. & Lanzavecchia, A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375, 148-151 (1995).
95. Wucherpfennig, K. W. & Strominger, J. L. Molecular mimicry in T-cell-mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 80, 695-705 (1995).
96. Gautam, A. M., Liblau, R., Chelvanayagam, G., Steinman, L. & Boston, T. A viral peptide with limited homology to a self. peptide can induce clinical signs of experimental autoimmune encephalomyelitis. J. Immunol. 161, 60-64 (1998).
97. Ufret-Vincenty, R. L. et al. In vivo survival of vital antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J. Exp. Med. 188, 1725-1738 (1998).
98. Ruiz, P. J. et al. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J. Exp. Med. 189, 1275-1284 (1999).
99. Murtaza, A., Kuchroo, V. K. & Freeman, G. J. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T-cell responses to altered peptide ligands. Int. Immunol. 11, 407-416 (1999).
100. Kissler, S., Anderton, S. M. & Wraith, D. C. Antigen-presenting cell activation: a link between infection and autoimmunity? J. Autoimmun. 16, 303-308 (2001).
101. Drakesmith, H., Chain, B. & Bevedey, P. How can dendritic cells cause autoimmune disease? Immunol. Today 21, 214-217 (2000).
102. Drakesmith, H. et al. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin-6 and native antigen. Proc. Natl Acad. Sci. USA 95, 14903-14908 (1998).
103. Manoury, B., Gregory, W. F., Maizels, R. M. & Watts, C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr. Biol. 11, 447-451 (2001).
104. Doyle, H. A. & Mamula, M. J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22, 443-449 (2001).
105. Evavold, B. D., Sloanlancaster, J. & Alien, P. M. Tickling the TCR - selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609 (1993).
106. H-cell proliferation by an altered T-cell receptor ligand. Science 252, 1308-1310 (1991).
107. De Magistris, M. T. et al. Antigen analog-major histocompatibility complexes act as antagonists of the T-cell receptor. Cell 68, 625-634 (1992).
108. Sloan-Lancaster, J. & Allen, P. M. Altered peptide ligand-induced partial T-cell activation: molecular mechanisms and role in T-cell biology. Annu. Rev. Immunol. 14, 1-27 (1996).
109. Anderton, S. M. Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology 104, 367-376 (2001).
110. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T-cell epitope mimicry? Nature Immunol. 2, 797-801 (2001).
111. Panoutsakopoulou, V. & Cantor, H. On the relationship between viral infection and autoimmunity. J. Autoimmun. 16, 341-345 (2001).
112. Albert, L. J. & Inman, R. D. Molecular mimicry and autoimmunity. N. Engl. J. Med. 341, 2068-2074 (1999).
113. Ohashi, P. S. et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen-transgenic mice Cell 65, 305-317 (1991).
114. Oldstone, M. B., Nerenberg, M., Southern, P., Price, J. & Lewicki, H. Virus infection tnggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65, 319-331 (1991).
115. Carrizosa, A. M. et al. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J. Immunol. 161, 3307-3314 (1998).
116. Padovan, E. et al. Expression of two T-cell receptor α-chains: dual receptor T cells. Science 262, 422-424 (1993).
117. Zal, T, Weiss, S., Mellor, A. & Stockinger, B. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function Proc. Natl Acad. Sci. USA 93, 9102-9107 (1996).